Skip to main content
Top

05-04-2024 | Atopic Dermatitis | Therapy in Practice

Secondary Bacterial Infections in Patients with Atopic Dermatitis or Other Common Dermatoses

Authors: Romain Salle, Pascal Del Giudice, Charbel Skayem, Camille Hua, Olivier Chosidow

Published in: American Journal of Clinical Dermatology

Login to get access

Abstract

Secondary bacterial infections of common dermatoses such as atopic dermatitis, ectoparasitosis, and varicella zoster virus infections are frequent, with Staphylococcus aureus and Streptococcus pyogenes being the bacteria most involved. There are also Gram-negative infections secondary to common dermatoses such as foot dyshidrotic eczema and tinea pedis. Factors favoring secondary bacterial infections in atopic dermatitis, ectoparasitosis, and varicella zoster virus infections mainly include an epidermal barrier alteration as well as itch. Mite-bacteria interaction is also involved in scabies and some environmental factors can promote Gram-negative bacterial infections of the feet. Furthermore, the bacterial ecology of these superinfections may depend on the geographical origin of the patients, especially in ectoparasitosis. Bacterial superinfections can also have different clinical aspects depending on the underlying dermatoses. Subsequently, the choice of class, course, and duration of antibiotic treatment depends on the severity of the infection and the suspected bacteria, primarily targeting S. aureus. Prevention of these secondary bacterial infections depends first and foremost on the management of the underlying skin disorder. At the same time, educating the patient on maintaining good skin hygiene and reporting changes in the primary lesions is crucial. In the case of recurrent secondary infections, decolonization of S. aureus is deemed necessary, particularly in atopic dermatitis.
Literature
1.
go back to reference Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.CrossRef Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.CrossRef
2.
go back to reference Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134:1527–34.PubMedCrossRef Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134:1527–34.PubMedCrossRef
3.
go back to reference Sandhu JK, Salame N, Ehsani-Chimeh N, Armstrong AW. Economic burden of cutaneous infections in children and adults with atopic dermatitis. Pediatr Dermatol. 2019;36:303–10.PubMedCrossRef Sandhu JK, Salame N, Ehsani-Chimeh N, Armstrong AW. Economic burden of cutaneous infections in children and adults with atopic dermatitis. Pediatr Dermatol. 2019;36:303–10.PubMedCrossRef
4.
go back to reference Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32:850–78.PubMedCrossRef Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32:850–78.PubMedCrossRef
5.
go back to reference Marcus E, Demmler D, Rudolph A, Fischer M. Bacterial colonization of psoriasis plaques. Is it relevant? Dermatol Rep. 2011;3: e14.CrossRef Marcus E, Demmler D, Rudolph A, Fischer M. Bacterial colonization of psoriasis plaques. Is it relevant? Dermatol Rep. 2011;3: e14.CrossRef
6.
go back to reference Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–60.PubMedCrossRef Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–60.PubMedCrossRef
7.
go back to reference Totté JEE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SGMA. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol. 2016;175:687–95.PubMedCrossRef Totté JEE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SGMA. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol. 2016;175:687–95.PubMedCrossRef
8.
go back to reference Ong PY, Leung DYM. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51:329–37.PubMedCrossRef Ong PY, Leung DYM. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51:329–37.PubMedCrossRef
9.
go back to reference Wang V, Keefer M, Ong PY. Antibiotic choice and methicillin-resistant Staphylococcus aureus rate in children hospitalized for atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122:314–7.PubMedCrossRef Wang V, Keefer M, Ong PY. Antibiotic choice and methicillin-resistant Staphylococcus aureus rate in children hospitalized for atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122:314–7.PubMedCrossRef
10.
go back to reference Mannschreck D, Feig J, Selph J, Cohen B. Disseminated bullous impetigo and atopic dermatitis: case series and literature review. Pediatr Dermatol. 2020;37:103–8.PubMedCrossRef Mannschreck D, Feig J, Selph J, Cohen B. Disseminated bullous impetigo and atopic dermatitis: case series and literature review. Pediatr Dermatol. 2020;37:103–8.PubMedCrossRef
11.
go back to reference Liy-Wong C, Pope E, Weinstein M, Lara-Corrales I. Staphylococcal scalded skin syndrome: an epidemiological and clinical review of 84 cases. Pediatr Dermatol. 2021;38:149–53.PubMedCrossRef Liy-Wong C, Pope E, Weinstein M, Lara-Corrales I. Staphylococcal scalded skin syndrome: an epidemiological and clinical review of 84 cases. Pediatr Dermatol. 2021;38:149–53.PubMedCrossRef
12.
go back to reference Vernali S, Blasiak RC, Morrell DS. Demographic characteristics, clinical features, and optimal management of hospitalized patients with staphylococcal scalded skin syndrome. Pediatr Dermatol. 2021;38:825–30.PubMedCrossRef Vernali S, Blasiak RC, Morrell DS. Demographic characteristics, clinical features, and optimal management of hospitalized patients with staphylococcal scalded skin syndrome. Pediatr Dermatol. 2021;38:825–30.PubMedCrossRef
13.
go back to reference Petry V, Bessa GR, Poziomczyck CS, de Oliveira CF, Weber MB, Bonamigo RR, et al. Bacterial skin colonization and infections in patients with atopic dermatitis. An Bras Dermatol. 2012;87:729–34.PubMedCrossRef Petry V, Bessa GR, Poziomczyck CS, de Oliveira CF, Weber MB, Bonamigo RR, et al. Bacterial skin colonization and infections in patients with atopic dermatitis. An Bras Dermatol. 2012;87:729–34.PubMedCrossRef
14.
go back to reference David Boothe W, Tarbox JA, Tarbox MB. Atopic dermatitis: pathophysiology. Adv Exp Med Biol. 2017;1027:21–37.PubMedCrossRef David Boothe W, Tarbox JA, Tarbox MB. Atopic dermatitis: pathophysiology. Adv Exp Med Biol. 2017;1027:21–37.PubMedCrossRef
15.
go back to reference Groner A, Laing-Grayman D, Silverberg NB. Outpatient pediatric community-acquired methicillin-resistant Staphylococcus aureus: a polymorphous clinical disease. Cutis. 2008;81:115–22.PubMed Groner A, Laing-Grayman D, Silverberg NB. Outpatient pediatric community-acquired methicillin-resistant Staphylococcus aureus: a polymorphous clinical disease. Cutis. 2008;81:115–22.PubMed
16.
go back to reference Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155:680–7.PubMedCrossRef Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155:680–7.PubMedCrossRef
17.
go back to reference Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015;42:756–66.PubMedPubMedCentralCrossRef Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015;42:756–66.PubMedPubMedCentralCrossRef
18.
go back to reference Silverberg JI, Silverberg NB. Childhood atopic dermatitis and warts are associated with increased risk of infection: a US population-based study. J Allergy Clin Immunol. 2014;133:1041–7.PubMedCrossRef Silverberg JI, Silverberg NB. Childhood atopic dermatitis and warts are associated with increased risk of infection: a US population-based study. J Allergy Clin Immunol. 2014;133:1041–7.PubMedCrossRef
19.
go back to reference Parsons JB, Yao J, Frank MW, Jackson P, Rock CO. Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus. J Bacteriol. 2012;194:5294–304.PubMedPubMedCentralCrossRef Parsons JB, Yao J, Frank MW, Jackson P, Rock CO. Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus. J Bacteriol. 2012;194:5294–304.PubMedPubMedCentralCrossRef
20.
go back to reference Ong PY, Leung DYM. Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep. 2006;6:384–9.PubMedCrossRef Ong PY, Leung DYM. Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep. 2006;6:384–9.PubMedCrossRef
21.
22.
go back to reference Strober W. Susceptibility of atopic dermatitis versus psoriasis to superinfection is related to production of β-defensins. Curr Allergy Asthma Rep. 2004;4:63–4.CrossRef Strober W. Susceptibility of atopic dermatitis versus psoriasis to superinfection is related to production of β-defensins. Curr Allergy Asthma Rep. 2004;4:63–4.CrossRef
23.
go back to reference Francis NA, Ridd MJ, Thomas-Jones E, Butler CC, Hood K, Shepherd V, et al. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Ann Fam Med. 2017;15:124–30.PubMedPubMedCentralCrossRef Francis NA, Ridd MJ, Thomas-Jones E, Butler CC, Hood K, Shepherd V, et al. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Ann Fam Med. 2017;15:124–30.PubMedPubMedCentralCrossRef
24.
go back to reference Galli L, Venturini E, Bassi A, Gattinara GC, Chiappini E, Defilippi C, et al. Common community-acquired bacterial skin and soft-tissue infections in children: an intersociety consensus on impetigo, abscess, and cellulitis treatment. Clin Ther. 2019;41:532-51.e17.PubMedCrossRef Galli L, Venturini E, Bassi A, Gattinara GC, Chiappini E, Defilippi C, et al. Common community-acquired bacterial skin and soft-tissue infections in children: an intersociety consensus on impetigo, abscess, and cellulitis treatment. Clin Ther. 2019;41:532-51.e17.PubMedCrossRef
25.
go back to reference Brazel M, Desai A, Are A, Motaparthi K. Staphylococcal scalded skin syndrome and bullous impetigo. Medicina (Kaunas). 2021;57:1157.PubMedCrossRef Brazel M, Desai A, Are A, Motaparthi K. Staphylococcal scalded skin syndrome and bullous impetigo. Medicina (Kaunas). 2021;57:1157.PubMedCrossRef
26.
go back to reference Patel GK, Finlay AY. Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol. 2003;4:165–75.PubMedCrossRef Patel GK, Finlay AY. Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol. 2003;4:165–75.PubMedCrossRef
27.
go back to reference Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol. 2014;28:1418–23.PubMedCrossRef Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol. 2014;28:1418–23.PubMedCrossRef
28.
go back to reference Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–74.PubMedCrossRef Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–74.PubMedCrossRef
29.
go back to reference Qualls ML, Mooney MM, Camargo CA, Zucconi T, Hooper DC, Pallin DJ. Emergency department visit rates for abscess versus other skin infections during the emergence of community-associated methicillin-resistant Staphylococcus aureus, 1997–2007. Clin Infect Dis. 2012;55:103–5.PubMedCrossRef Qualls ML, Mooney MM, Camargo CA, Zucconi T, Hooper DC, Pallin DJ. Emergency department visit rates for abscess versus other skin infections during the emergence of community-associated methicillin-resistant Staphylococcus aureus, 1997–2007. Clin Infect Dis. 2012;55:103–5.PubMedCrossRef
30.
go back to reference Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10-52.PubMedCrossRef Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10-52.PubMedCrossRef
31.
go back to reference Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev. 2014;27:264–301.PubMedPubMedCentralCrossRef Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev. 2014;27:264–301.PubMedPubMedCentralCrossRef
32.
go back to reference Patel D, Jahnke MN. Serious complications from Staphylococcal aureus in atopic dermatitis. Pediatr Dermatol. 2015;32:792–6.PubMedCrossRef Patel D, Jahnke MN. Serious complications from Staphylococcal aureus in atopic dermatitis. Pediatr Dermatol. 2015;32:792–6.PubMedCrossRef
33.
go back to reference George SM, Karanovic S, Harrison DA, Rani A, Birnie AJ, Bath-Hextall FJ, et al. Interventions to reduce Staphylococcus aureus in the management of eczema. Cochrane Database Syst Rev. 2019;2019:CD003871.PubMedPubMedCentral George SM, Karanovic S, Harrison DA, Rani A, Birnie AJ, Bath-Hextall FJ, et al. Interventions to reduce Staphylococcus aureus in the management of eczema. Cochrane Database Syst Rev. 2019;2019:CD003871.PubMedPubMedCentral
34.
go back to reference Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LWA, Morris AD, Butler CC, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012;1:CD003261.PubMed Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LWA, Morris AD, Butler CC, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012;1:CD003261.PubMed
35.
go back to reference Vogel A, Lennon D, Best E, Leversha A. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. N Z Med J. 2016;129:77–83.PubMed Vogel A, Lennon D, Best E, Leversha A. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. N Z Med J. 2016;129:77–83.PubMed
36.
go back to reference Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-55.PubMedCrossRef Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-55.PubMedCrossRef
37.
go back to reference Chen AE, Carroll KC, Diener-West M, Ross T, Ordun J, Goldstein MA, et al. Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections. Pediatrics. 2011;127:e573–80.PubMedPubMedCentralCrossRef Chen AE, Carroll KC, Diener-West M, Ross T, Ordun J, Goldstein MA, et al. Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections. Pediatrics. 2011;127:e573–80.PubMedPubMedCentralCrossRef
39.
go back to reference Bouchiat C, Curtis S, Spiliopoulou I, Bes M, Cocuzza C, Codita I, et al. MRSA infections among patients in the emergency department: a European multicentre study. J Antimicrob Chemother. 2017;72:372–5.PubMedCrossRef Bouchiat C, Curtis S, Spiliopoulou I, Bes M, Cocuzza C, Codita I, et al. MRSA infections among patients in the emergency department: a European multicentre study. J Antimicrob Chemother. 2017;72:372–5.PubMedCrossRef
40.
go back to reference Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014;90:229–35.PubMed Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014;90:229–35.PubMed
41.
go back to reference Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, et al. A placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med. 2017;376:2545–55.PubMedPubMedCentralCrossRef Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, et al. A placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med. 2017;376:2545–55.PubMedPubMedCentralCrossRef
42.
go back to reference Mounsey A, Lacy Smith K, Reddy VC, Nickolich S. Clostridioides difficile infection: update on management. Am Fam Physician. 2020;101:168–75.PubMed Mounsey A, Lacy Smith K, Reddy VC, Nickolich S. Clostridioides difficile infection: update on management. Am Fam Physician. 2020;101:168–75.PubMed
43.
go back to reference Bowen AC, Tong SYC, Andrews RM, O’Meara IM, McDonald MI, Chatfield MD, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet. 2014;384:2132–40.PubMedCrossRef Bowen AC, Tong SYC, Andrews RM, O’Meara IM, McDonald MI, Chatfield MD, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet. 2014;384:2132–40.PubMedCrossRef
44.
go back to reference Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374:823–32.PubMedPubMedCentralCrossRef Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374:823–32.PubMedPubMedCentralCrossRef
45.
go back to reference Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med. 2015;372:1093–103.PubMedPubMedCentralCrossRef Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med. 2015;372:1093–103.PubMedPubMedCentralCrossRef
46.
go back to reference Rae N, Jarchow-MacDonald A, Nathwani D, Marwick CA. MRSA: treating people with infection. BMJ Clin Evid. 2016;2016:0922.PubMedPubMedCentral Rae N, Jarchow-MacDonald A, Nathwani D, Marwick CA. MRSA: treating people with infection. BMJ Clin Evid. 2016;2016:0922.PubMedPubMedCentral
47.
go back to reference Hua C, Urbina T, Bosc R, Parks T, Sriskandan S, de Prost N, et al. Necrotising soft-tissue infections. Lancet Infect Dis. 2023;23(3):e81-94.PubMedCrossRef Hua C, Urbina T, Bosc R, Parks T, Sriskandan S, de Prost N, et al. Necrotising soft-tissue infections. Lancet Infect Dis. 2023;23(3):e81-94.PubMedCrossRef
48.
go back to reference Wang Z, Feig JL, Mannschreck DB, Cohen BA. Antibiotic sensitivity and clinical outcomes in staphylococcal scalded skin syndrome. Pediatr Dermatol. 2020;37:222–3.PubMedCrossRef Wang Z, Feig JL, Mannschreck DB, Cohen BA. Antibiotic sensitivity and clinical outcomes in staphylococcal scalded skin syndrome. Pediatr Dermatol. 2020;37:222–3.PubMedCrossRef
49.
go back to reference Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong PY, Silverberg J, Farrar JR. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120:10-22.e2.PubMedCrossRef Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong PY, Silverberg J, Farrar JR. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120:10-22.e2.PubMedCrossRef
50.
go back to reference Hung S-H, Lin Y-T, Chu C-Y, Lee C-C, Liang T-C, Yang Y-H, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol. 2007;98:51–6.PubMedCrossRef Hung S-H, Lin Y-T, Chu C-Y, Lee C-C, Liang T-C, Yang Y-H, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol. 2007;98:51–6.PubMedCrossRef
51.
go back to reference Gonzalez ME, Schaffer JV, Orlow SJ, Gao Z, Li H, Alekseyenko AV, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75:481-93.e8.PubMedPubMedCentralCrossRef Gonzalez ME, Schaffer JV, Orlow SJ, Gao Z, Li H, Alekseyenko AV, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75:481-93.e8.PubMedPubMedCentralCrossRef
52.
go back to reference Callewaert C, Nakatsuji T, Knight R, Kosciolek T, Vrbanac A, Kotol P, et al. IL-4Rα blockade by dupilumab decreases Staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis. J Invest Dermatol. 2020;140:191-202.e7.PubMedCrossRef Callewaert C, Nakatsuji T, Knight R, Kosciolek T, Vrbanac A, Kotol P, et al. IL-4Rα blockade by dupilumab decreases Staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis. J Invest Dermatol. 2020;140:191-202.e7.PubMedCrossRef
53.
go back to reference Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126:3–12.PubMedCrossRef Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126:3–12.PubMedCrossRef
54.
go back to reference Magdaleno-Tapial J, Martínez-Doménech A, Valenzuela-Oñate C, Ferrer-Guillén B, Esteve-Martínez A, Zaragoza-Ninet V. Allergic contact dermatitis to chlorhexidine in pediatric patients. Pediatr Dermatol. 2019;36:540–1.PubMedCrossRef Magdaleno-Tapial J, Martínez-Doménech A, Valenzuela-Oñate C, Ferrer-Guillén B, Esteve-Martínez A, Zaragoza-Ninet V. Allergic contact dermatitis to chlorhexidine in pediatric patients. Pediatr Dermatol. 2019;36:540–1.PubMedCrossRef
55.
go back to reference Hong F, Salmon S, Ong XY, Liew K, Koh Y, Young A, et al. Routine antiseptic baths and MRSA decolonization: diverse approaches across Singapore’s acute-care hospitals. J Hosp Infect. 2021;112:87–91.PubMedCrossRef Hong F, Salmon S, Ong XY, Liew K, Koh Y, Young A, et al. Routine antiseptic baths and MRSA decolonization: diverse approaches across Singapore’s acute-care hospitals. J Hosp Infect. 2021;112:87–91.PubMedCrossRef
56.
go back to reference Chow A, Hon PY, Tin G, Zhang W, Poh BF, Ang B. Intranasal octenidine and universal antiseptic bathing reduce methicillin-resistant Staphylococcus aureus (MRSA) prevalence in extended care facilities. Epidemiol Infect. 2018;146:2036–41.PubMedPubMedCentralCrossRef Chow A, Hon PY, Tin G, Zhang W, Poh BF, Ang B. Intranasal octenidine and universal antiseptic bathing reduce methicillin-resistant Staphylococcus aureus (MRSA) prevalence in extended care facilities. Epidemiol Infect. 2018;146:2036–41.PubMedPubMedCentralCrossRef
57.
go back to reference Harris PNA, Le BD, Tambyah P, Hsu LY, Pada S, Archuleta S, et al. Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: a cluster crossover study. Open Forum Infect Dis. 2015;2:ofv051.PubMedPubMedCentralCrossRef Harris PNA, Le BD, Tambyah P, Hsu LY, Pada S, Archuleta S, et al. Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: a cluster crossover study. Open Forum Infect Dis. 2015;2:ofv051.PubMedPubMedCentralCrossRef
58.
go back to reference Hardy K, Sunnucks K, Gil H, Shabir S, Trampari E, Hawkey P, et al. Increased usage of antiseptics is associated with reduced susceptibility in clinical isolates of Staphylococcus aureus. MBio. 2018;9: e00894-18.PubMedPubMedCentralCrossRef Hardy K, Sunnucks K, Gil H, Shabir S, Trampari E, Hawkey P, et al. Increased usage of antiseptics is associated with reduced susceptibility in clinical isolates of Staphylococcus aureus. MBio. 2018;9: e00894-18.PubMedPubMedCentralCrossRef
59.
go back to reference Chopra R, Vakharia PP, Sacotte R, Silverberg JI. Efficacy of bleach baths in reducing severity of atopic dermatitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2017;119:435–40.PubMedPubMedCentralCrossRef Chopra R, Vakharia PP, Sacotte R, Silverberg JI. Efficacy of bleach baths in reducing severity of atopic dermatitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2017;119:435–40.PubMedPubMedCentralCrossRef
60.
go back to reference Takatsuji T, Gallo RL, Shafiq F, Tong Y, Chun K, Butcher AM, Cheng JY, Hata TR. Use of autologous bacteriotherapy to treat Staphylococcus aureus in patients with atopic dermatitis: a randomized double-blind clinical trial. JAMA Dermatol. 2021;157:978–82.CrossRef Takatsuji T, Gallo RL, Shafiq F, Tong Y, Chun K, Butcher AM, Cheng JY, Hata TR. Use of autologous bacteriotherapy to treat Staphylococcus aureus in patients with atopic dermatitis: a randomized double-blind clinical trial. JAMA Dermatol. 2021;157:978–82.CrossRef
61.
go back to reference Worth C, Heukelbach J, Fengler G, Walter B, Liesenfeld O, Hengge U, et al. Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin. Pediatr Dermatol. 2012;29:430–6.PubMedCrossRef Worth C, Heukelbach J, Fengler G, Walter B, Liesenfeld O, Hengge U, et al. Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin. Pediatr Dermatol. 2012;29:430–6.PubMedCrossRef
62.
go back to reference Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the developing world: its prevalence, complications, and management. Clin Microbiol Infect. 2012;18:313–23.PubMedCrossRef Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the developing world: its prevalence, complications, and management. Clin Microbiol Infect. 2012;18:313–23.PubMedCrossRef
63.
go back to reference Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685–94.PubMedCrossRef Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685–94.PubMedCrossRef
64.
go back to reference Engelman D, Kiang K, Chosidow O, McCarthy J, Fuller C, Lammie P, et al. Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis. 2013;7: e2167.PubMedPubMedCentralCrossRef Engelman D, Kiang K, Chosidow O, McCarthy J, Fuller C, Lammie P, et al. Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis. 2013;7: e2167.PubMedPubMedCentralCrossRef
65.
go back to reference Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, et al. The public health control of scabies: priorities for research and action. Lancet. 2019;394:81–92.PubMedCrossRef Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, et al. The public health control of scabies: priorities for research and action. Lancet. 2019;394:81–92.PubMedCrossRef
66.
go back to reference Streeton CL, Hanna JN, Messer RD, Merianos A. An epidemic of acute post-streptococcal glomerulonephritis among aboriginal children. J Paediatr Child Health. 1995;31:245–8.PubMedCrossRef Streeton CL, Hanna JN, Messer RD, Merianos A. An epidemic of acute post-streptococcal glomerulonephritis among aboriginal children. J Paediatr Child Health. 1995;31:245–8.PubMedCrossRef
67.
go back to reference Thornley S, Marshall R, Jarrett P, Sundborn G, Reynolds E, Schofield G. Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children. J Paediatr Child Health. 2018;54:625–32.PubMedCrossRef Thornley S, Marshall R, Jarrett P, Sundborn G, Reynolds E, Schofield G. Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children. J Paediatr Child Health. 2018;54:625–32.PubMedCrossRef
68.
go back to reference Steer AC, Jenney AWJ, Kado J, Batzloff MR, La Vincente S, Waqatakirewa L, et al. High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis. 2009;3: e467.PubMedPubMedCentralCrossRef Steer AC, Jenney AWJ, Kado J, Batzloff MR, La Vincente S, Waqatakirewa L, et al. High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis. 2009;3: e467.PubMedPubMedCentralCrossRef
69.
go back to reference Jenney A, Holt D, Ritika R, Southwell P, Pravin S, Buadromo E, et al. The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji. BMC Infect Dis. 2014;14:160.PubMedPubMedCentralCrossRef Jenney A, Holt D, Ritika R, Southwell P, Pravin S, Buadromo E, et al. The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji. BMC Infect Dis. 2014;14:160.PubMedPubMedCentralCrossRef
70.
go back to reference Marks M, Romani L, Sokana O, Neko L, Harrington R, Nasi T, et al. Prevalence of scabies and impetigo 3 years after mass drug administration with ivermectin and azithromycin. Clin Infect Dis. 2020;70:1591–5.PubMedCrossRef Marks M, Romani L, Sokana O, Neko L, Harrington R, Nasi T, et al. Prevalence of scabies and impetigo 3 years after mass drug administration with ivermectin and azithromycin. Clin Infect Dis. 2020;70:1591–5.PubMedCrossRef
71.
go back to reference Skayem C, Majda A, Gary C, Hemery F, Mahé E, Caux F, et al. Severe scabies: a French multi-centre study involving 95 patients with crusted and profuse disease and review of the literature. Acta Derm Venereol. 2023;103:adv00878.PubMedCrossRef Skayem C, Majda A, Gary C, Hemery F, Mahé E, Caux F, et al. Severe scabies: a French multi-centre study involving 95 patients with crusted and profuse disease and review of the literature. Acta Derm Venereol. 2023;103:adv00878.PubMedCrossRef
72.
go back to reference Thomas C, Coates SJ, Engelman D, Chosidow O, Chang AY. Ectoparasites: scabies. J Am Acad Dermatol. 2020;82:533–48.PubMedCrossRef Thomas C, Coates SJ, Engelman D, Chosidow O, Chang AY. Ectoparasites: scabies. J Am Acad Dermatol. 2020;82:533–48.PubMedCrossRef
73.
go back to reference Reynolds SL, Pike RN, Mika A, Blom AM, Hofmann A, Wijeyewickrema LC, et al. Scabies mite inactive serine proteases are potent inhibitors of the human complement lectin pathway. PLoS Negl Trop Dis. 2014;8: e2872.PubMedPubMedCentralCrossRef Reynolds SL, Pike RN, Mika A, Blom AM, Hofmann A, Wijeyewickrema LC, et al. Scabies mite inactive serine proteases are potent inhibitors of the human complement lectin pathway. PLoS Negl Trop Dis. 2014;8: e2872.PubMedPubMedCentralCrossRef
74.
go back to reference Swe PM, Fischer K. A scabies mite serpin interferes with complement-mediated neutrophil functions and promotes staphylococcal growth. PLoS Negl Trop Dis. 2014;8: e2928.PubMedPubMedCentralCrossRef Swe PM, Fischer K. A scabies mite serpin interferes with complement-mediated neutrophil functions and promotes staphylococcal growth. PLoS Negl Trop Dis. 2014;8: e2928.PubMedPubMedCentralCrossRef
75.
go back to reference Swe PM, Christian LD, Lu HC, Sriprakash KS, Fischer K. Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes: an in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions. PLoS Negl Trop Dis. 2017;11: e0005437.PubMedPubMedCentralCrossRef Swe PM, Christian LD, Lu HC, Sriprakash KS, Fischer K. Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes: an in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions. PLoS Negl Trop Dis. 2017;11: e0005437.PubMedPubMedCentralCrossRef
76.
go back to reference Swe PM, Zakrzewski M, Kelly A, Krause L, Fischer K. Scabies mites alter the skin microbiome and promote growth of opportunistic pathogens in a porcine model. PLoS Negl Trop Dis. 2014;8: e2897.PubMedPubMedCentralCrossRef Swe PM, Zakrzewski M, Kelly A, Krause L, Fischer K. Scabies mites alter the skin microbiome and promote growth of opportunistic pathogens in a porcine model. PLoS Negl Trop Dis. 2014;8: e2897.PubMedPubMedCentralCrossRef
77.
go back to reference Yeoh DK, Bowen AC, Carapetis JR. Impetigo and scabies: disease burden and modern treatment strategies. J Infect. 2016;72(Suppl.):S61–7.PubMedCrossRef Yeoh DK, Bowen AC, Carapetis JR. Impetigo and scabies: disease burden and modern treatment strategies. J Infect. 2016;72(Suppl.):S61–7.PubMedCrossRef
78.
go back to reference Thean LJ, Jenney A, Engelman D, Romani L, Wand H, Mudaliar J, et al. Hospital admissions for skin and soft tissue infections in a population with endemic scabies: a prospective study in Fiji, 2018–2019. PLoS Negl Trop Dis. 2020;14: e0008887.PubMedPubMedCentralCrossRef Thean LJ, Jenney A, Engelman D, Romani L, Wand H, Mudaliar J, et al. Hospital admissions for skin and soft tissue infections in a population with endemic scabies: a prospective study in Fiji, 2018–2019. PLoS Negl Trop Dis. 2020;14: e0008887.PubMedPubMedCentralCrossRef
79.
go back to reference Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101:e119–25.PubMedCrossRef Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101:e119–25.PubMedCrossRef
80.
go back to reference Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2018;378:971.PubMed Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2018;378:971.PubMed
81.
go back to reference Salle R, Hua C, Mongereau M, Giraud-Kerleroux L, Gary C, Fiani C, et al. Challenges and limitations of teledermatology for skin and soft-tissue infections: a real-world study of an expert center. J Am Acad Dermatol. 2023;88:457–9.PubMedCrossRef Salle R, Hua C, Mongereau M, Giraud-Kerleroux L, Gary C, Fiani C, et al. Challenges and limitations of teledermatology for skin and soft-tissue infections: a real-world study of an expert center. J Am Acad Dermatol. 2023;88:457–9.PubMedCrossRef
82.
go back to reference Andrews RM, Kearns T, Connors C, Parker C, Carville K, Currie BJ, et al. A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis. 2009;3: e554.PubMedPubMedCentralCrossRef Andrews RM, Kearns T, Connors C, Parker C, Carville K, Currie BJ, et al. A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis. 2009;3: e554.PubMedPubMedCentralCrossRef
83.
go back to reference Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, Wate C, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ. 2005;83:34–42.PubMedPubMedCentral Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, Wate C, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ. 2005;83:34–42.PubMedPubMedCentral
84.
86.
go back to reference Nilsson SF, Ali Z, Laursen TM, Thyssen JP, Egeberg A, Nordentoft M, et al. Association of homelessness and skin conditions: a Danish population-based cohort study. Br J Dermatol. 2023;188:760–9.PubMedCrossRef Nilsson SF, Ali Z, Laursen TM, Thyssen JP, Egeberg A, Nordentoft M, et al. Association of homelessness and skin conditions: a Danish population-based cohort study. Br J Dermatol. 2023;188:760–9.PubMedCrossRef
87.
go back to reference Chosidow O, Chang AY. The skin of people experiencing homelessness: more (known) is less (neglected). Br J Dermatol. 2023;188:694–5.PubMedCrossRef Chosidow O, Chang AY. The skin of people experiencing homelessness: more (known) is less (neglected). Br J Dermatol. 2023;188:694–5.PubMedCrossRef
88.
go back to reference Arnaud A, Chosidow O, Détrez M-A, Bitar D, Huber F, Foulet F, et al. Prevalences of scabies and pediculosis corporis among homeless people in the Paris region: results from two randomized cross-sectional surveys (HYTPEAC study). Br J Dermatol. 2016;174:104–12.PubMedCrossRef Arnaud A, Chosidow O, Détrez M-A, Bitar D, Huber F, Foulet F, et al. Prevalences of scabies and pediculosis corporis among homeless people in the Paris region: results from two randomized cross-sectional surveys (HYTPEAC study). Br J Dermatol. 2016;174:104–12.PubMedCrossRef
89.
go back to reference Bonilla DL, Cole-Porse C, Kjemtrup A, Osikowicz L, Kosoy M. Risk factors for human lice and bartonellosis among the homeless, San Francisco, California, USA. Emerg Infect Dis. 2014;20:1645–51.PubMedPubMedCentralCrossRef Bonilla DL, Cole-Porse C, Kjemtrup A, Osikowicz L, Kosoy M. Risk factors for human lice and bartonellosis among the homeless, San Francisco, California, USA. Emerg Infect Dis. 2014;20:1645–51.PubMedPubMedCentralCrossRef
90.
go back to reference Drali R, Sangaré AK, Boutellis A, Angelakis E, Veracx A, Socolovschi C, et al. Bartonella quintana in body lice from scalp hair of homeless persons. France Emerg Infect Dis. 2014;20:907–8.PubMedCrossRef Drali R, Sangaré AK, Boutellis A, Angelakis E, Veracx A, Socolovschi C, et al. Bartonella quintana in body lice from scalp hair of homeless persons. France Emerg Infect Dis. 2014;20:907–8.PubMedCrossRef
91.
go back to reference Faccini-Martínez ÁA, Márquez AC, Bravo-Estupiñan DM, Calixto O-J, López-Castillo CA, Botero-García CA, et al. Bartonella quintana and typhus group Rickettsiae exposure among homeless persons, Bogotá. Colombia Emerg Infect Dis. 2017;23:1876–9.PubMedCrossRef Faccini-Martínez ÁA, Márquez AC, Bravo-Estupiñan DM, Calixto O-J, López-Castillo CA, Botero-García CA, et al. Bartonella quintana and typhus group Rickettsiae exposure among homeless persons, Bogotá. Colombia Emerg Infect Dis. 2017;23:1876–9.PubMedCrossRef
92.
go back to reference Ulutasdemir N, Eroglu F, Tanrıverdi M, Dagli EI, Koltas IS. The epidemic typhus and trench fever are risk for public health due to increased migration in southeast of Turkey. Acta Trop. 2018;178:115–8.PubMedCrossRef Ulutasdemir N, Eroglu F, Tanrıverdi M, Dagli EI, Koltas IS. The epidemic typhus and trench fever are risk for public health due to increased migration in southeast of Turkey. Acta Trop. 2018;178:115–8.PubMedCrossRef
93.
go back to reference Louni M, Mana N, Bitam I, Dahmani M, Parola P, Fenollar F, et al. Body lice of homeless people reveal the presence of several emerging bacterial pathogens in northern Algeria. PLoS Negl Trop Dis. 2018;12: e0006397.PubMedPubMedCentralCrossRef Louni M, Mana N, Bitam I, Dahmani M, Parola P, Fenollar F, et al. Body lice of homeless people reveal the presence of several emerging bacterial pathogens in northern Algeria. PLoS Negl Trop Dis. 2018;12: e0006397.PubMedPubMedCentralCrossRef
94.
go back to reference Antinori S, Mediannikov O, Corbellino M, Raoult D. Louse-borne relapsing fever among East African refugees in Europe. Travel Med Infect Dis. 2016;14:110–4.PubMedCrossRef Antinori S, Mediannikov O, Corbellino M, Raoult D. Louse-borne relapsing fever among East African refugees in Europe. Travel Med Infect Dis. 2016;14:110–4.PubMedCrossRef
95.
go back to reference Nordmann T, Feldt T, Bosselmann M, Tufa TB, Lemma G, Holtfreter M, et al. Outbreak of louse-borne relapsing fever among urban dwellers in Arsi zone, Central Ethiopia, from July to November 2016. Am J Trop Med Hyg. 2018;98:1599–602.PubMedPubMedCentralCrossRef Nordmann T, Feldt T, Bosselmann M, Tufa TB, Lemma G, Holtfreter M, et al. Outbreak of louse-borne relapsing fever among urban dwellers in Arsi zone, Central Ethiopia, from July to November 2016. Am J Trop Med Hyg. 2018;98:1599–602.PubMedPubMedCentralCrossRef
96.
go back to reference Karunamoorthi K. Tungiasis: a neglected epidermal parasitic skin disease of marginalized populations—a call for global science and policy. Parasitol Res. 2013;112:3635–43.PubMedCrossRef Karunamoorthi K. Tungiasis: a neglected epidermal parasitic skin disease of marginalized populations—a call for global science and policy. Parasitol Res. 2013;112:3635–43.PubMedCrossRef
97.
go back to reference Feldmeier H, Heukelbach J, Eisele M, Sousa AQ, Barbosa LM, Carvalho CB. Bacterial superinfection in human tungiasis. Trop Med Int Health. 2002;7:559–64.PubMedCrossRef Feldmeier H, Heukelbach J, Eisele M, Sousa AQ, Barbosa LM, Carvalho CB. Bacterial superinfection in human tungiasis. Trop Med Int Health. 2002;7:559–64.PubMedCrossRef
98.
go back to reference Nyangacha RM, Odongo D, Oyieke F, Ochwoto M, Korir R, Ngetich RK, et al. Secondary bacterial infections and antibiotic resistance among tungiasis patients in Western, Kenya. PLoS Negl Trop Dis. 2017;11: e0005901.PubMedPubMedCentralCrossRef Nyangacha RM, Odongo D, Oyieke F, Ochwoto M, Korir R, Ngetich RK, et al. Secondary bacterial infections and antibiotic resistance among tungiasis patients in Western, Kenya. PLoS Negl Trop Dis. 2017;11: e0005901.PubMedPubMedCentralCrossRef
99.
go back to reference Coates SJ, Thomas C, Chosidow O, Engelman D, Chang AY. Ectoparasites: pediculosis and tungiasis. J Am Acad Dermatol. 2020;82:551–69.PubMedCrossRef Coates SJ, Thomas C, Chosidow O, Engelman D, Chang AY. Ectoparasites: pediculosis and tungiasis. J Am Acad Dermatol. 2020;82:551–69.PubMedCrossRef
100.
101.
go back to reference Rolain J-M, Foucault C, Guieu R, La Scola B, Brouqui P, Raoult D. Bartonella quintana in human erythrocytes. Lancet. 2002;360:226–8.PubMedCrossRef Rolain J-M, Foucault C, Guieu R, La Scola B, Brouqui P, Raoult D. Bartonella quintana in human erythrocytes. Lancet. 2002;360:226–8.PubMedCrossRef
104.
go back to reference Badiaga S, Brouqui P. Human louse-transmitted infectious diseases. Clin Microbiol Infect. 2012;18:332–7.PubMedCrossRef Badiaga S, Brouqui P. Human louse-transmitted infectious diseases. Clin Microbiol Infect. 2012;18:332–7.PubMedCrossRef
105.
go back to reference Jenkins NE, Ferguson DJP, Alp NJ, Harrison TG, Bowler ICJW. Urban trench fever presenting as culture-negative endocarditis. QJM. 2009;102:63–5.PubMedCrossRef Jenkins NE, Ferguson DJP, Alp NJ, Harrison TG, Bowler ICJW. Urban trench fever presenting as culture-negative endocarditis. QJM. 2009;102:63–5.PubMedCrossRef
106.
go back to reference Moulin C, Kanitakis J, Ranchin B, Chauvet C, Gillet Y, Morelon E, et al. Cutaneous bacillary angiomatosis in renal transplant recipients: report of three new cases and literature review. Transpl Infect Dis. 2012;14:403–9.PubMedCrossRef Moulin C, Kanitakis J, Ranchin B, Chauvet C, Gillet Y, Morelon E, et al. Cutaneous bacillary angiomatosis in renal transplant recipients: report of three new cases and literature review. Transpl Infect Dis. 2012;14:403–9.PubMedCrossRef
107.
go back to reference Raoult D, Ndihokubwayo JB, Tissot-Dupont H, Roux V, Faugere B, Abegbinni R, et al. Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet. 1998;352:353–8.PubMedCrossRef Raoult D, Ndihokubwayo JB, Tissot-Dupont H, Roux V, Faugere B, Abegbinni R, et al. Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet. 1998;352:353–8.PubMedCrossRef
109.
go back to reference Mitjà O, Marks M, Bertran L, Kollie K, Argaw D, Fahal AH, et al. Integrated control and management of neglected tropical skin diseases. PLoS Negl Trop Dis. 2017;11: e0005136.PubMedPubMedCentralCrossRef Mitjà O, Marks M, Bertran L, Kollie K, Argaw D, Fahal AH, et al. Integrated control and management of neglected tropical skin diseases. PLoS Negl Trop Dis. 2017;11: e0005136.PubMedPubMedCentralCrossRef
110.
go back to reference La Scola B, Raoult D. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol. 1999;37:1899–905.PubMedPubMedCentralCrossRef La Scola B, Raoult D. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol. 1999;37:1899–905.PubMedPubMedCentralCrossRef
111.
go back to reference Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents. 2014;44:16–25.PubMedCrossRef Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents. 2014;44:16–25.PubMedCrossRef
112.
113.
go back to reference Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15:645–57.PubMedCrossRef Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15:645–57.PubMedCrossRef
114.
go back to reference Bozzola E, Bozzola M, Krzysztofiak A, Tozzi AE, El Hachem M, Villani A. Varicella skin complications in childhood: a case series and a systematic review of the literature. Int J Mol Sci. 2016;17:688.PubMedPubMedCentralCrossRef Bozzola E, Bozzola M, Krzysztofiak A, Tozzi AE, El Hachem M, Villani A. Varicella skin complications in childhood: a case series and a systematic review of the literature. Int J Mol Sci. 2016;17:688.PubMedPubMedCentralCrossRef
115.
go back to reference Diniz LMO, Maia MMM, de Oliveira YV, Mourão MSF, Couto AV, Mota VC, et al. Study of complications of varicella-zoster virus infection in hospitalized children at a reference hospital for infectious disease treatment. Hosp Pediatr. 2018;8:419–25.PubMedCrossRef Diniz LMO, Maia MMM, de Oliveira YV, Mourão MSF, Couto AV, Mota VC, et al. Study of complications of varicella-zoster virus infection in hospitalized children at a reference hospital for infectious disease treatment. Hosp Pediatr. 2018;8:419–25.PubMedCrossRef
116.
go back to reference Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996;335:547–54.PubMedCrossRef Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996;335:547–54.PubMedCrossRef
117.
go back to reference Babamahmoodi F, Alikhani A, Ahangarkani F, Delavarian L, Barani H, Babamahmoodi A. Clinical manifestations of herpes zoster, its comorbidities, and its complications in North of Iran from 2007 to 2013. Neurol Res Int. 2015;2015: 896098.PubMedPubMedCentral Babamahmoodi F, Alikhani A, Ahangarkani F, Delavarian L, Barani H, Babamahmoodi A. Clinical manifestations of herpes zoster, its comorbidities, and its complications in North of Iran from 2007 to 2013. Neurol Res Int. 2015;2015: 896098.PubMedPubMedCentral
118.
go back to reference Bieńkowski C, Talarek E, Pokorska-Śpiewak M. The clinical course of herpes zoster is similar in immunocompetent and immunocompromised paediatric patients. J Paediatr Child Health. 2023;59:1112–4.PubMedCrossRef Bieńkowski C, Talarek E, Pokorska-Śpiewak M. The clinical course of herpes zoster is similar in immunocompetent and immunocompromised paediatric patients. J Paediatr Child Health. 2023;59:1112–4.PubMedCrossRef
119.
go back to reference Dubos F, Grandbastien B, Hue V, Hospital Network for Evaluating Management of Common Childhood Diseases, Martinot A. Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect. 2007;135:131–8.PubMedCrossRef Dubos F, Grandbastien B, Hue V, Hospital Network for Evaluating Management of Common Childhood Diseases, Martinot A. Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect. 2007;135:131–8.PubMedCrossRef
120.
go back to reference Elena B, Anna Q, Andrzej K, Elisabetta P, Laura L, Alberto T. Haematological complications in otherwise healthy children hospitalized for varicella. Vaccine. 2011;29:1534–7.PubMedCrossRef Elena B, Anna Q, Andrzej K, Elisabetta P, Laura L, Alberto T. Haematological complications in otherwise healthy children hospitalized for varicella. Vaccine. 2011;29:1534–7.PubMedCrossRef
121.
go back to reference Veraldi S, Schianchi R. Herpes zoster, bacterial superinfections and antibiotics. J Dermatolog Treat. 2007;18:255.PubMedCrossRef Veraldi S, Schianchi R. Herpes zoster, bacterial superinfections and antibiotics. J Dermatolog Treat. 2007;18:255.PubMedCrossRef
122.
go back to reference Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nat Rev Dis Prim. 2015;1:15016.PubMedCrossRef Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nat Rev Dis Prim. 2015;1:15016.PubMedCrossRef
123.
go back to reference Dauger S, Blondé R, Brissaud O, Marcoux M-O, Angoulvant F, Levy M, et al. Necrotizing soft-tissue infections in pediatric intensive care: a prospective multicenter case-series study. Crit Care. 2021;25:139.PubMedPubMedCentralCrossRef Dauger S, Blondé R, Brissaud O, Marcoux M-O, Angoulvant F, Levy M, et al. Necrotizing soft-tissue infections in pediatric intensive care: a prospective multicenter case-series study. Crit Care. 2021;25:139.PubMedPubMedCentralCrossRef
125.
go back to reference Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics. 1999;103:783–90.PubMedCrossRef Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics. 1999;103:783–90.PubMedCrossRef
126.
go back to reference Weidner T, Tittelbach J, Illing T, Elsner P. Gram-negative bacterial toe web infection: a systematic review. J Eur Acad Dermatol Venereol. 2018;32:39–47.PubMedCrossRef Weidner T, Tittelbach J, Illing T, Elsner P. Gram-negative bacterial toe web infection: a systematic review. J Eur Acad Dermatol Venereol. 2018;32:39–47.PubMedCrossRef
127.
go back to reference Goiset A, Milpied B, Marti A, Marie J, Leroy-Colavolpe V, Pham-Ledard A, et al. Characteristics, associated diseases, and management of Gram-negative toe-web infection: a French experience. Acta Derm Venereol. 2019;99:1121–6.PubMed Goiset A, Milpied B, Marti A, Marie J, Leroy-Colavolpe V, Pham-Ledard A, et al. Characteristics, associated diseases, and management of Gram-negative toe-web infection: a French experience. Acta Derm Venereol. 2019;99:1121–6.PubMed
128.
go back to reference Solomon M, Greenbaum H, Shemer A, Barzilai A, Baum S. Toe web infection: epidemiology and risk factors in a large cohort study. Dermatology. 2021;237:902–6.PubMedCrossRef Solomon M, Greenbaum H, Shemer A, Barzilai A, Baum S. Toe web infection: epidemiology and risk factors in a large cohort study. Dermatology. 2021;237:902–6.PubMedCrossRef
129.
go back to reference Leyden JJ, Kligman AM. Interdigital athlete’s foot: the interaction of dermatophytes and resident bacteria. Arch Dermatol. 1978;114:1466–72.PubMedCrossRef Leyden JJ, Kligman AM. Interdigital athlete’s foot: the interaction of dermatophytes and resident bacteria. Arch Dermatol. 1978;114:1466–72.PubMedCrossRef
130.
go back to reference Hojyo-Tomoka MT, Marples RR, Kligman AM. Pseudomonas infection in superhydrated skin. Arch Dermatol. 1973;107:723–7.PubMedCrossRef Hojyo-Tomoka MT, Marples RR, Kligman AM. Pseudomonas infection in superhydrated skin. Arch Dermatol. 1973;107:723–7.PubMedCrossRef
131.
go back to reference Aste N, Atzori L, Zucca M, Pau M, Biggio P. Gram-negative bacterial toe web infection: a survey of 123 cases from the district of Cagliari. Italy J Am Acad Dermatol. 2001;45:537–41.PubMedCrossRef Aste N, Atzori L, Zucca M, Pau M, Biggio P. Gram-negative bacterial toe web infection: a survey of 123 cases from the district of Cagliari. Italy J Am Acad Dermatol. 2001;45:537–41.PubMedCrossRef
132.
go back to reference Gupta AK, Skinner AR, Cooper EA. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. Int J Dermatol. 2005;44:590–3.PubMedCrossRef Gupta AK, Skinner AR, Cooper EA. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. Int J Dermatol. 2005;44:590–3.PubMedCrossRef
133.
go back to reference Kim M-C, Kim S, Cho EB, Lee GY, Choi S-H, Kim SO, et al. Utility of magnetic resonance imaging for differentiating necrotizing fasciitis from severe cellulitis: a magnetic resonance indicator for necrotizing fasciitis (MRINEC) algorithm. J Clin Med. 2020;9:3040.PubMedPubMedCentralCrossRef Kim M-C, Kim S, Cho EB, Lee GY, Choi S-H, Kim SO, et al. Utility of magnetic resonance imaging for differentiating necrotizing fasciitis from severe cellulitis: a magnetic resonance indicator for necrotizing fasciitis (MRINEC) algorithm. J Clin Med. 2020;9:3040.PubMedPubMedCentralCrossRef
134.
go back to reference Sartelli M, Guirao X, Hardcastle TC, Kluger Y, Boermeester MA, Raşa K, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13:58.PubMedPubMedCentralCrossRef Sartelli M, Guirao X, Hardcastle TC, Kluger Y, Boermeester MA, Raşa K, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13:58.PubMedPubMedCentralCrossRef
135.
go back to reference Babiker A, Li X, Lai YL, Strich JR, Warner S, Sarzynski S, et al. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. Lancet Infect Dis. 2021;21:697–710.PubMedCrossRef Babiker A, Li X, Lai YL, Strich JR, Warner S, Sarzynski S, et al. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. Lancet Infect Dis. 2021;21:697–710.PubMedCrossRef
136.
go back to reference Salle R, Chosidow O, Fihman V, de Prost N, Zeghbib N, Woerther P-L, et al. Clindamycin resistance in Group A streptococcal infections: a single-centre retrospective cohort study of 186 patients. J Eur Acad Dermatol Venereol. 2023;37:e888–9.PubMedCrossRef Salle R, Chosidow O, Fihman V, de Prost N, Zeghbib N, Woerther P-L, et al. Clindamycin resistance in Group A streptococcal infections: a single-centre retrospective cohort study of 186 patients. J Eur Acad Dermatol Venereol. 2023;37:e888–9.PubMedCrossRef
Metadata
Title
Secondary Bacterial Infections in Patients with Atopic Dermatitis or Other Common Dermatoses
Authors
Romain Salle
Pascal Del Giudice
Charbel Skayem
Camille Hua
Olivier Chosidow
Publication date
05-04-2024
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-024-00856-1